Related references
Note: Only part of the references are listed.Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model
G. Liang et al.
GENE THERAPY (2016)
Atorvastatin inhibits miR-143 expression: A protective mechanism against oxidative stress in cardiomyocytes
Shanshan Tian et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
A network-biology perspective of microRNA function and dysfunction in cancer
Cameron P. Bracken et al.
NATURE REVIEWS GENETICS (2016)
ROS homeostasis and metabolism: a dangerous liason in cancer cells
E. Panieri et al.
CELL DEATH & DISEASE (2016)
miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells
Sofia E. Gomes et al.
ONCOTARGET (2016)
Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis
Ani V. Das et al.
CANCER CELL INTERNATIONAL (2015)
Characterization of antiproliferative potential and biological targets of a copper compound containing 4'-phenyl terpyridine
Ana Soraia Mendo et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2015)
NON-CODING RNA Towards a molecular understanding of microRNA-mediated gene silencing
Stefanie Jonas et al.
NATURE REVIEWS GENETICS (2015)
miRNA-17 Members that Target Bmpr2 Influence Signaling Mechanisms Important for Embryonic Stem Cell Differentiation In Vitro and Gastrulation in Embryos
Shannon M. Larabee et al.
STEM CELLS AND DEVELOPMENT (2015)
Targeting SOD1 induces synthetic lethal killing in BLM- and CHEK2-deficient colorectal cancer cells
Babu V. Sajesh et al.
ONCOTARGET (2015)
Glycoursodeoxycholic Acid Reduces Matrix Metalloproteinase-9 and Caspase-9 Activation in a Cellular Model of Superoxide Dismutase-1 Neurodegeneration
Ana Rita Vaz et al.
MOLECULAR NEUROBIOLOGY (2015)
MicroRNA biogenesis pathways in cancer
Shuibin Lin et al.
NATURE REVIEWS CANCER (2015)
Peroxiredoxin 2 knockdown by RNA interference inhibits the growth of colorectal cancer cells by downregulating Wnt/β-catenin signaling
Weidong Lu et al.
CANCER LETTERS (2014)
Targeting SOD1 reduces experimental non-small-cell lung cancer
Andrea Glasauer et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis
Joao Conde et al.
NANOTOXICOLOGY (2014)
MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers
Xu Qian et al.
CELL CYCLE (2013)
Molecular Pathways: Reactive Oxygen Species Homeostasis in Cancer Cells and Implications for Cancer Therapy
Veronique Nogueira et al.
CLINICAL CANCER RESEARCH (2013)
Delivering the promise of miRNA cancer therapeutics
Diane M. Pereira et al.
DRUG DISCOVERY TODAY (2013)
Synthetic Lethal Targeting of Superoxide Dismutase 1 Selectively Kills RAD54B-Deficient Colorectal Cancer Cells
Babu V. Sajesh et al.
GENETICS (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets
O. A. Kent et al.
ONCOGENE (2013)
Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression
A. Pagliuca et al.
ONCOGENE (2013)
Roles for MicroRNAs in Conferring Robustness to Biological Processes
Margaret S. Ebert et al.
CELL (2012)
MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis (Publication with Expression of Concern. See MAR, 2023)
Qing Xu et al.
NUCLEIC ACIDS RESEARCH (2012)
MicroRNA-145 Protects Cardiomyocytes against Hydrogen Peroxide (H2O2)-Induced Apoptosis through Targeting the Mitochondria Apoptotic Pathway
Ruotian Li et al.
PLOS ONE (2012)
EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet-Promoted Murine Colon Cancer: Role of G1 Regulators
Hongyan Zhu et al.
MOLECULAR CANCER RESEARCH (2011)
Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice
Dipankar Pramanik et al.
MOLECULAR CANCER THERAPEUTICS (2011)
miR-143 Overexpression Impairs Growth of Human Colon Carcinoma Xenografts in Mice with Induction of Apoptosis and Inhibition of Proliferation
Pedro M. Borralho et al.
PLOS ONE (2011)
Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines
Romel Somwar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress
Alice T. Shaw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Systematic analysis of off-target effects in an RNAi screen reveals microRNAs affecting sensitivity to TRAIL-induced apoptosis
Ian Sudbery et al.
BMC GENOMICS (2010)
The functional significance of microRNA-145 in prostate cancer
M. S. Zaman et al.
BRITISH JOURNAL OF CANCER (2010)
MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1
Mohit Sachdeva et al.
CANCER RESEARCH (2010)
The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin
Anamaria Brozovic et al.
CRITICAL REVIEWS IN TOXICOLOGY (2010)
Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway
Oliver A. Kent et al.
GENES & DEVELOPMENT (2010)
MiR-145, a new regulator of the DNA Fragmentation Factor-45 (DFF45)-mediated apoptotic network
Jianjun Zhang et al.
MOLECULAR CANCER (2010)
Identification of non-coding RNAs embracing microRNA-143/145 cluster
Akio Iio et al.
MOLECULAR CANCER (2010)
Making RISC
Tomoko Kawamata et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells
Pedro M. Borralho et al.
FEBS JOURNAL (2009)
Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells
Yukihiro Akao et al.
LEUKEMIA RESEARCH (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
Role of miR-143 targeting KRAS in colorectal tumorigenesis
X. Chen et al.
ONCOGENE (2009)
Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)
F. Donate et al.
BRITISH JOURNAL OF CANCER (2008)
Systemic treatment of colorectal cancer
Brian M. Wolpin et al.
GASTROENTEROLOGY (2008)
Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling
Jose C. Juarez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Apoptosis by cisplatin requires p53 mediated p38α MAPK activation through ROS generation
Paloma Bragado et al.
APOPTOSIS (2007)
Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2
Yong Zhao et al.
CELL (2007)
Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1
Jose C. Juarez et al.
CLINICAL CANCER RESEARCH (2006)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
